Sandbox:Sahar: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 8: | Line 8: | ||
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| Pathologic appearance}} | ! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| Pathologic appearance}} | ||
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| Other features}} | ! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| Other features}} | ||
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| Pathologic view}} | |||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC; " align="left" |Angiolipoma | ! style="padding: 5px 5px; background: #DCDCDC; " align="left" |Angiolipoma | ||
Line 29: | Line 30: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Benign | * Benign | ||
| | |||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC; " align="left" |Myolipoma | ! style="padding: 5px 5px; background: #DCDCDC; " align="left" |Myolipoma | ||
Line 54: | Line 56: | ||
* Benign | * Benign | ||
* It is usually large and located in the deep soft tissues | * It is usually large and located in the deep soft tissues | ||
| | |||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC; " align="left" |Myelolipoma | ! style="padding: 5px 5px; background: #DCDCDC; " align="left" |Myelolipoma | ||
Line 83: | Line 84: | ||
* Well-circumscribed radiolucent mass in radiologic imaging | * Well-circumscribed radiolucent mass in radiologic imaging | ||
* May have hromonal activity | * May have hromonal activity | ||
| | |||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC; " align="left" |Spindle Cell/Pleomorphic Lipoma | ! style="padding: 5px 5px; background: #DCDCDC; " align="left" |Spindle Cell/Pleomorphic Lipoma | ||
Line 112: | Line 112: | ||
* Immunohistochemically positive for CD34 | * Immunohistochemically positive for CD34 | ||
* Benign | * Benign | ||
| | |||
|- | |- | ||
!style="padding: 5px 5px; background: #DCDCDC; " align="left" |Chondroid Lipoma | !style="padding: 5px 5px; background: #DCDCDC; " align="left" |Chondroid Lipoma | ||
Line 139: | Line 138: | ||
* Heterogeneous soft tissue mass in radiologic imaging | * Heterogeneous soft tissue mass in radiologic imaging | ||
* Benign | * Benign | ||
| | |||
|- | |- | ||
!style="padding: 5px 5px; background: #DCDCDC; " align="left" |Hibernoma | !style="padding: 5px 5px; background: #DCDCDC; " align="left" |Hibernoma | ||
Line 166: | Line 164: | ||
* Immunohistochemically positive for S-100 | * Immunohistochemically positive for S-100 | ||
* Benign | * Benign | ||
| | |||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC; " align="left" |Lipomas of Tendon Sheaths and Joints | ! style="padding: 5px 5px; background: #DCDCDC; " align="left" |Lipomas of Tendon Sheaths and Joints | ||
Line 177: | Line 174: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| | |||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC; " align="left"|Intramuscular and Intermuscular Lipomas | ! style="padding: 5px 5px; background: #DCDCDC; " align="left"|Intramuscular and Intermuscular Lipomas | ||
Line 185: | Line 183: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| | |||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC; " align="left"|Neural Fibrolipoma | ! style="padding: 5px 5px; background: #DCDCDC; " align="left"|Neural Fibrolipoma | ||
Line 193: | Line 192: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| | |||
|} | |} | ||
Revision as of 22:02, 13 November 2019
Lipomatous tumor | Age of onset | Gender preponderance | Location | Clinical features | Pathologic appearance | Other features | Pathologic view |
---|---|---|---|---|---|---|---|
Angiolipoma |
|
|
|
|
|
|
|
Myolipoma |
|
|
|
|
|
|
|
Myelolipoma |
|
|
|
|
|
|
|
Spindle Cell/Pleomorphic Lipoma |
|
|
|
|
|
|
|
Chondroid Lipoma |
|
|
|
|
|
|
|
Hibernoma |
|
|
|
|
|
|
|
Lipomas of Tendon Sheaths and Joints |
|
||||||
Intramuscular and Intermuscular Lipomas | |||||||
Neural Fibrolipoma |
Example #1
The patient presented with S.O.B. one year after hysterectomy for a leiomyomatous uterus.